Get unlimited access to our best features
Subscribe now

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

Summary by Ground News
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released a second white paper. The White Paper describes the use of HTG’s Transcriptome Panel (HTP) in early-stage design, selection and characterization of small-molecule candidates.
1 month ago·Tucson, United States

News Articles

More Filters
All
Left
Center
Right
Globe Newswire

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., July 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...

1 month ago
Read Full Article

Similar News Topics

Show All
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

No sources with tracked biases.
See less detail